09:40 AM EDT, 05/29/2024 (MT Newswires) -- Catalent ( CTLT ) said Wednesday its shareholders have approved its pending merger with Novo Holdings, the parent company of Novo Nordisk ( NVO ) .

Under the terms, Novo Holdings will acquire all outstanding Catalent ( CTLT ) shares for $63.50 apiece, the company added.

Catalent ( CTLT ) said it expects the transaction to be completed by the end of this year, subject to required regulatory approvals.

Price: 54.19, Change: +0.19, Percent Change: +0.35